Semaglutide vs Tirzepatide for Weight Loss: An APRN’s Comparison
Key Takeaways Semaglutide activates GLP-1 receptors; tirzepatide activates both GLP-1 and GIP receptors, giving it a dual hormonal mechanism that typically produces greater weight loss in clinical trials. Published trials show tirzepatide produced an average of 20-22% body weight reduction at the highest dose versus approximately 14.9% for semaglutide. Both are clinically meaningful, and individual […]